10,581 Shares in Amrize Ltd $AMRZ Acquired by O Brien Greene & Co. Inc

O Brien Greene & Co. Inc bought a new position in Amrize Ltd (NYSE:AMRZ) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,581 shares of the company’s stock, valued at approximately $572,000.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Amrize by 41.0% during the third quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company’s stock valued at $1,468,460,000 after purchasing an additional 8,743,543 shares during the period. Wellington Management Group LLP grew its position in Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after acquiring an additional 3,809,133 shares during the period. Marshall Wace LLP grew its position in Amrize by 865.4% in the third quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock valued at $139,436,000 after acquiring an additional 2,590,336 shares during the period. Amundi bought a new stake in Amrize in the third quarter valued at $104,047,000. Finally, Cannell & Spears LLC acquired a new position in Amrize in the third quarter worth $53,387,000.

Insider Buying and Selling at Amrize

In other news, CFO Ian A. Johnston purchased 4,250 shares of the business’s stock in a transaction dated Tuesday, March 10th. The shares were acquired at an average price of $58.94 per share, with a total value of $250,495.00. Following the completion of the purchase, the chief financial officer directly owned 25,110 shares of the company’s stock, valued at $1,479,983.40. The trade was a 20.37% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jan Philipp Jenisch purchased 60,000 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were purchased at an average cost of $58.05 per share, for a total transaction of $3,483,000.00. Following the purchase, the chief executive officer directly owned 1,703,582 shares of the company’s stock, valued at $98,892,935.10. This trade represents a 3.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 77,836 shares of company stock valued at $4,511,449 over the last ninety days. Company insiders own 0.54% of the company’s stock.

Amrize Trading Down 3.7%

Shares of AMRZ opened at $48.98 on Friday. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $65.94. The firm has a market capitalization of $27.09 billion and a PE ratio of 23.44. The stock’s fifty day simple moving average is $55.74 and its 200-day simple moving average is $55.14.

Amrize (NYSE:AMRZ) last issued its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The firm had revenue of $2.18 billion for the quarter. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. As a group, research analysts predict that Amrize Ltd will post 2.7 earnings per share for the current year.

Amrize Cuts Dividend

The company also recently declared a dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.

Analysts Set New Price Targets

AMRZ has been the topic of a number of recent analyst reports. Royal Bank Of Canada reduced their price objective on Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Truist Financial reduced their price objective on Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. JPMorgan Chase & Co. boosted their price objective on Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a research note on Thursday, March 5th. Morgan Stanley reissued an “overweight” rating and issued a $65.00 price objective on shares of Amrize in a research note on Wednesday, May 6th. Finally, Citigroup reduced their price objective on Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Amrize currently has an average rating of “Moderate Buy” and an average price target of $64.50.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.